Stay updated on AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.

Latest updates to the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedA new Study Status entry was added to the history on 2026-06-29 (version 81, Revision: v3.6.3), and an older 2025-11-10 entry (Revision: v3.6.2) was removed, updating the study's status history and versioning.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision in the footer updated from v3.6.0 to v3.6.2, indicating a minor version update to the page metadata.SummaryDifference0.0%

- Check41 days agoChange DetectedRecruitment status updated to no longer enrolling. The record history also shows a version update to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4 in the page footer, indicating a small system version update. No study details or results are modified.SummaryDifference0.0%

- Check70 days agoChange DetectedThe record history includes a new revision entry v3.5.4, indicating a subsequent update to the study’s listing in ClinicalTrials.gov.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a system-level update for this page. The visible study data and navigation remain unchanged.SummaryDifference0.0%

Stay in the know with updates to AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.